Design Therapeutics (DSGN) Amortizatization of Intangibles (2020 - 2026)

Design Therapeutics' (DSGN) quarterly Amortizatization of Intangibles came in at $147000.0 in Q1 2026, down 86.13% year-on-year from $1.1 million in Q1 2025, and down 71.29% quarter-over-quarter from $512000.0 in Q4 2025.

Design Therapeutics (DSGN) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Design Therapeutics has disclosed Amortizatization of Intangibles across 7 years of filings, most recently posting $147000.0 for Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $147000.0, down 86.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (down 57.66% YoY), and the FY2025 annual result was $3.3 million, down 47.52% from the prior year.
  • Amortizatization of Intangibles came in at $147000.0 for Q1 2026 at Design Therapeutics, down from $512000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $6.1 million in Q4 2023 to a low of -$19000.0 in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $767000.0 (2025), against an average of $1.0 million.
  • Across the five-year window, Amortizatization of Intangibles slumped 112.67% in 2022 and jumped 18100.0% in 2024, its largest moves.
  • Design Therapeutics' Amortizatization of Intangibles stood at $899000.0 in 2022, then surged by 573.64% to $6.1 million in 2023, then tumbled by 76.25% to $1.4 million in 2024, then plunged by 64.39% to $512000.0 in 2025, then plunged by 71.29% to $147000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $147000.0 (Q1 2026), $512000.0 (Q4 2025), and $767000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Design Therapeutics 763.94 Mn 541.11 Mn - 147,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 147,000.00
Mar 31, 2026 147,000.00
Dec 31, 2025 512,000.00
Dec 31, 2025 512,000.00
Sep 30, 2025 767,000.00
Sep 30, 2025 767,000.00
Jun 30, 2025 914,000.00
Jun 30, 2025 914,000.00
Mar 31, 2025 1.06 Mn
Mar 31, 2025 1.06 Mn
Dec 31, 2024 1.44 Mn
Dec 31, 2024 1.44 Mn
Sep 30, 2024 1.46 Mn
Sep 30, 2024 1.46 Mn
Jun 30, 2024 1.57 Mn
Jun 30, 2024 1.57 Mn
Mar 31, 2024 1.73 Mn
Mar 31, 2024 1.73 Mn
Dec 31, 2023 6.06 Mn
Dec 31, 2023 6.06 Mn